title: Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis.
abstract: Pemphigoid gestationis (PG) is an autoimmune blistering disease associated with pregnancy. It is characterized by the presence of autoantibodies against bullous pemphigoid antigens in the basement membrane zone. A 32 year old female developed PG in the first pregnancy and had a stillbirth. PG recurred during the second trimester of her second pregnancy. Systemic corticosteroid therapy was cause for concern since patient developed gestational diabetes. Patient was unwilling to use insulin. Intravenous immunoglobulin (IVIg) was used as a treatment of last resort. The dose was 2g/kg/cycle. It was given every two weeks antepartum and every three weeks for three months postpartum. PG improved within four weeks of IVIg therapy. Serum and tissue immunopathological studies were negative prior to delivery. A healthy neonate was born. No adverse events to IVIg were observed. No disease was observed ten months postpartum.
authors.affiliation: Center for Blistering Diseases, 697 Cambridge St, Boston, MA, USA.
authors.forename: Tegan
authors.initials: T
authors.lastname: Nguyen
authors.affiliation: Asaad Alhamad Center for Dermatology, Kuwait City, Kuwait.
authors.forename: Esraa
authors.initials: E
authors.lastname: Alraqum
authors.affiliation: Center for Blistering Diseases, 697 Cambridge St, Boston, MA, USA. Electronic address: arahmedmd@msn.com.
authors.forename: A
authors.initials: A
authors.lastname: Razzaque Ahmed
mesh_terms: D000328:Adult; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007155:Immunologic Factors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006559:Pemphigoid Gestationis / Q000188:drug therapy* / Q000276:immunology; D011247:Pregnancy; D011256:Pregnancy Outcome; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors
keywords: Autoimmune disease; Intravenous immunoglobulin; Pemphigoid gestationis